v3.25.2
Earnings Per Share (Schedule of Basic and Diluted Earnings Per Share) (Details) - USD ($)
$ / shares in Units, $ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2025
Jun. 30, 2024
Jun. 30, 2025
Jun. 30, 2024
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Net income $ 111 $ 92 $ 148 $ 126
Weighted-average common shares outstanding 73,500,000 77,700,000 74,100,000 78,000,000
Weighted-average common shares outstanding - assuming dilution 74,700,000 78,100,000 75,300,000 78,500,000
Basic earnings per share (in dollars per share) $ 1.51 $ 1.18 $ 2 $ 1.61
Diluted earnings per share (in dollars per share) $ 1.48 $ 1.18 $ 1.96 $ 1.6
Restricted Stock Units [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Effect of dilutive securities [1] 700,000 400,000 700,000 500,000
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 1,304 3,093 389,970 428,235
Stock Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Effect of dilutive securities [2] 300,000 100,000 300,000 0
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 770,881 1,504,925 438,547 1,299,171
Performance Options [Member]        
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]        
Effect of dilutive securities [3] 300,000 0 300,000 0
Antidilutive securities excluded from computation of diluted earnings per share (in shares) 0 274,282 0 274,282
[1] RSUs of 1,304 shares and 3,093 shares for the three months ended June 30, 2025 and 2024, respectively, and 389,970 shares and 428,235 shares for the six months ended June 30, 2025 and 2024, respectively, were not included in the diluted earnings per share calculation because their effect would have been anti-dilutive.
[2] Stock options to purchase 770,881 shares and 1,504,925 shares for the three months ended June 30, 2025 and 2024, respectively, and 438,547 shares and 1,299,171 shares for the six months ended June 30, 2025 and 2024, respectively, were not included in the diluted earnings per share calculation because their effect would have been anti-dilutive.
[3] Performance options to purchase 274,282 shares for each of the three and six months ended June 30, 2024 were not included in the diluted earnings per share calculation because their effect would have been anti-dilutive. There were no anti-dilutive shares of performance options for the three and six months ended June 30, 2025.